Lymphopenia in critically ill COVID-19 patients: A predictor factor of severity and mortality.
作者信息
Ziadi Amra, Hachimi Abdelhamid, Admou Brahim, Hazime Raja, Brahim Imane, Douirek Fouzia, Zarrouki Youssef, El Adib Ahmed R, Younous Said, Samkaoui Abdenasser M
机构信息
Polyvalent Intensive Care Unit, Arrazi Hospital, Mohammed VIth Teaching Center, Cadi Ayyad University, Marrakech, Morocco.
Medical Intensive Care Unit, Arrazi Hospital, Mohammed VIth Teaching Center, Cadi Ayyad University, Marrakech, Morocco.
出版信息
Int J Lab Hematol. 2021 Feb;43(1):e38-e40. doi: 10.1111/ijlh.13351. Epub 2020 Sep 30.
Abstract
摘要
相似文献
1
Lymphopenia in critically ill COVID-19 patients: A predictor factor of severity and mortality.危重症COVID-19患者的淋巴细胞减少：严重程度和死亡率的预测因素。
Int J Lab Hematol. 2021 Feb;43(1):e38-e40. doi: 10.1111/ijlh.13351. Epub 2020 Sep 30.
2
Advancing insights in critical COVID-19: unraveling lymphopenia through propensity score matching - Findings from the Multicenter LYMPH-COVID Study.新冠肺炎关键进展：通过倾向评分匹配揭示淋巴细胞减少症——多中心LYMPH-COVID研究的结果
Crit Care Sci. 2024 Sep 27;36:e20240236en. doi: 10.62675/2965-2774.20240236-en. eCollection 2024.
3
Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study.铁代谢和 ICU 患者 COVID-19 感染期间的淋巴细胞特征：一项观察性队列研究。
World J Emerg Surg. 2020 Jun 30;15(1):41. doi: 10.1186/s13017-020-00323-2.
4
Intensive Care Unit Strain and Mortality Risk Among Critically Ill Patients With COVID-19-There Is No "Me" in COVID.新型冠状病毒肺炎重症患者的重症监护病房压力与死亡风险——新冠疫情中没有“我”置身事外。
JAMA Netw Open. 2021 Jan 4;4(1):e2035041. doi: 10.1001/jamanetworkopen.2020.35041.
5
Thrombotic complications in critically ill patients with COVID 19.新型冠状病毒肺炎（COVID-19）危重症患者的血栓形成并发症
Thromb Res. 2020 Jul;191:56. doi: 10.1016/j.thromres.2020.04.032. Epub 2020 Apr 30.
6
Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient.对一名重症COVID-19患者进行白细胞介素-7同情用药的免疫监测。
Cell Mol Immunol. 2020 Sep;17(9):1001-1003. doi: 10.1038/s41423-020-0516-6. Epub 2020 Jul 29.
7
Excess COVID-19 mortality among critically ill patients in Africa.非洲重症患者中新冠病毒病超额死亡率
Lancet. 2021 May 22;397(10288):1860-1861. doi: 10.1016/S0140-6736(21)00576-6.
8
[Recommendation of respiratory rehabilitation for PICS in critically ill patients with COVID-19].[新型冠状病毒肺炎危重症患者慢性重症期的呼吸康复建议]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Sep 12;43(9):737-743. doi: 10.3760/cma.j.cn112147-20200512-00592.
9
Immunological Subpopulations Within Critically Ill COVID-19 Patients.危重症 COVID-19 患者的免疫亚群
Chest. 2021 May;159(5):1706-1708. doi: 10.1016/j.chest.2021.01.023. Epub 2021 Feb 18.
10
Clotting abnormalities in critically ill COVID-19 patients are inconsistent with overt disseminated intravascular coagulation.危重症COVID-19患者的凝血异常与明显的弥散性血管内凝血不一致。
Thromb Res. 2020 Dec;196:272-275. doi: 10.1016/j.thromres.2020.09.015. Epub 2020 Sep 13.
引用本文的文献
1
A Study on Mortality Predictors in Hemodialysis Patients Infected with COVID-19: Impact of Vaccination Status.新冠病毒感染的血液透析患者死亡率预测因素研究：疫苗接种状况的影响
Vaccines (Basel). 2023 Dec 19;12(1):2. doi: 10.3390/vaccines12010002.
2
An explanatory analytics framework for early detection of chronic risk factors in pandemics.一种用于在大流行中早期检测慢性风险因素的解释性分析框架。
Healthc Anal (N Y). 2022 Nov;2:100020. doi: 10.1016/j.health.2022.100020. Epub 2022 Jan 10.
3
Use of Remdesivir in Patients with SARS-CoV-2 Pneumonia in a Real-Life Setting during the Second and Third COVID-19 Epidemic Waves.在第二波和第三波 COVID-19 疫情期间，在真实环境中使用瑞德西韦治疗 SARS-CoV-2 肺炎患者。
Viruses. 2023 Apr 11;15(4):947. doi: 10.3390/v15040947.
4
An algorithm to predict the need for invasive mechanical ventilation in hospitalized COVID-19 patients: the experience in Sao Paulo.一种预测住院COVID-19患者有创机械通气需求的算法：圣保罗的经验。
Acute Crit Care. 2022 Nov;37(4):580-591. doi: 10.4266/acc.2022.00283. Epub 2022 Sep 8.
5
T cell perturbations persist for at least 6 months following hospitalization for COVID-19.T 细胞紊乱在 COVID-19 住院后至少持续 6 个月。
Front Immunol. 2022 Aug 8;13:931039. doi: 10.3389/fimmu.2022.931039. eCollection 2022.
6
Reliability of predictive models to support early decision making in the emergency department for patients with confirmed diagnosis of COVID-19: the Pescara Covid Hospital score.用于支持确诊 COVID-19 患者在急诊科早期决策的预测模型的可靠性：佩斯卡拉 COVID 医院评分。
BMC Health Serv Res. 2022 Aug 19;22(1):1062. doi: 10.1186/s12913-022-08421-4.
7
Transient drop in the neutrophil count during COVID-19 regardless of clozapine treatment in patients with mental illness.患有精神疾病的患者在感染新冠病毒期间，无论是否接受氯氮平治疗，中性粒细胞计数都会出现短暂下降。
Rev Psiquiatr Salud Ment (Engl Ed). 2022 Apr-Jun;15(2):134-137. doi: 10.1016/j.rpsmen.2022.06.006.
8
The Role of Biomarkers in Hospitalized COVID-19 Patients With Systemic Manifestations.生物标志物在伴有全身表现的COVID-19住院患者中的作用
Biomark Insights. 2022 Jun 26;17:11772719221108909. doi: 10.1177/11772719221108909. eCollection 2022.
9
Clinical Characteristics in Patients with Redetected Positive RNA Test After Recovery from Foreign-Imported COVID-19 Cases in Xi'an, China.中国西安境外输入型新冠肺炎病例康复后核酸检测再次阳性患者的临床特征
Infect Drug Resist. 2022 Jun 24;15:3295-3307. doi: 10.2147/IDR.S371088. eCollection 2022.
10
The Role of Exposomes in the Pathophysiology of Autoimmune Diseases II: Pathogens.暴露组在自身免疫性疾病病理生理学中的作用II：病原体
Pathophysiology. 2022 Jun 3;29(2):243-280. doi: 10.3390/pathophysiology29020020.
Zotero 插件